Search research articles
Contact Us
Filters
Showing results (51-60 of 59) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 59 results.
Paediatrics & Child Health
|
March 5, 2016
The Edmonton Obesity Staging System for Pediatrics: A proposed clinical staging system for paediatric obesity
Stasia Hadjiyannakis, Annick Buchholz, Jean-Pierre Chanoine, et al.
Molecular Cancer Therapeutics
|
June 21, 2012
The HSP90 inhibitor, AT13387, is effective against imatinib-sensitive and -resistant gastrointestinal stromal tumor models
Tomoko Smyth, Thomas Van Looy, Jayne E Curry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 16, 2014
The novel, small-molecule DNA methylation inhibitor SGI-110 as an ovarian cancer chemosensitizer
Fang Fang, Joanne Munck, Jessica Tang, et al.
Investigational New Drugs
|
June 18, 2015
Phase I study of the heat shock protein 90 (Hsp90) inhibitor onalespib (AT13387) administered on a daily for 2 consecutive days per week dosing schedule in patients with advanced solid tumors
Khanh Do, Giovanna Speranza, Lun-Ching Chang, et al.
Science (New York, N.Y.)
|
May 6, 2026
A 481-meter-high landslide-tsunami in a cruise ship-frequented Alaska fjord
Dan H Shugar, Katherine R Barnhart, Mira Berdahl, et al.
Cancer Chemotherapy and Pharmacology
|
October 23, 2020
Phase 1 study of the HSP90 inhibitor onalespib in combination with AT7519, a pan-CDK inhibitor, in patients with advanced solid tumors
Khanh T Do, Geraldine O'Sullivan Coyne, John L Hays, et al.
Psicothema
|
July 12, 2017
[Therapeutic Residential Care for Children and Youth: A Consensus Statement of the International Work Group on Therapeutic Residential Care]
James K Whittaker, Lisa Holmes, Jorge F Del Valle, et al.
Molecular Cancer Therapeutics
|
July 19, 2011
Potent, selective inhibitors of fibroblast growth factor receptor define fibroblast growth factor dependence in preclinical cancer models
Matthew Squires, George Ward, Gordan Saxty, et al.
Science (New York, N.Y.)
|
May 13, 2022
Atmospheric waves and global seismoacoustic observations of the January 2022 Hunga eruption, Tonga
Robin S Matoza, David Fee, Jelle D Assink, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 59) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 59 results.
Paediatrics & Child Health
|
March 5, 2016
The Edmonton Obesity Staging System for Pediatrics: A proposed clinical staging system for paediatric obesity
Stasia Hadjiyannakis, Annick Buchholz, Jean-Pierre Chanoine, et al.
Molecular Cancer Therapeutics
|
June 21, 2012
The HSP90 inhibitor, AT13387, is effective against imatinib-sensitive and -resistant gastrointestinal stromal tumor models
Tomoko Smyth, Thomas Van Looy, Jayne E Curry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 16, 2014
The novel, small-molecule DNA methylation inhibitor SGI-110 as an ovarian cancer chemosensitizer
Fang Fang, Joanne Munck, Jessica Tang, et al.
Investigational New Drugs
|
June 18, 2015
Phase I study of the heat shock protein 90 (Hsp90) inhibitor onalespib (AT13387) administered on a daily for 2 consecutive days per week dosing schedule in patients with advanced solid tumors
Khanh Do, Giovanna Speranza, Lun-Ching Chang, et al.
Science (New York, N.Y.)
|
May 6, 2026
A 481-meter-high landslide-tsunami in a cruise ship-frequented Alaska fjord
Dan H Shugar, Katherine R Barnhart, Mira Berdahl, et al.
Cancer Chemotherapy and Pharmacology
|
October 23, 2020
Phase 1 study of the HSP90 inhibitor onalespib in combination with AT7519, a pan-CDK inhibitor, in patients with advanced solid tumors
Khanh T Do, Geraldine O'Sullivan Coyne, John L Hays, et al.
Psicothema
|
July 12, 2017
[Therapeutic Residential Care for Children and Youth: A Consensus Statement of the International Work Group on Therapeutic Residential Care]
James K Whittaker, Lisa Holmes, Jorge F Del Valle, et al.
Molecular Cancer Therapeutics
|
July 19, 2011
Potent, selective inhibitors of fibroblast growth factor receptor define fibroblast growth factor dependence in preclinical cancer models
Matthew Squires, George Ward, Gordan Saxty, et al.
Science (New York, N.Y.)
|
May 13, 2022
Atmospheric waves and global seismoacoustic observations of the January 2022 Hunga eruption, Tonga
Robin S Matoza, David Fee, Jelle D Assink, et al.
Page
of 6